Is Rocket Lab stock overvalued after the new high?

Shares look expensive on traditional metrics. Price to sales is near 79, price to book about 35, and earnings remain negative. The premium assumes Neutron ramps on time and lifts margins. If execution misses or pricing weakens, the multiple can compress quickly from these levels.

What could trigger a pullback in Rocket Lab stock soon?

Three near-term risks stand out. A Neutron schedule slip, weaker launch pricing due to SpaceX pressure, or cautious guidance on March 3, 2026. Overbought technicals also raise reversal odds. Loss of support near the middle Bollinger band around US$65 could invite faster profit taking.

How should Canadian investors manage currency risk with RKLB?

RKLB trades in US dollars, so CAD-based holders face FX swings. You can size positions smaller, stagger buys, or use a USD cash balance to match exposure. Some investors add a simple currency hedge when the loonie is weak. Always align any hedge with your holding period.

What milestones could support the bull case from here?

Clear progress on Neutron hardware, ground testing, and a confirmed mid 2026 first flight would help. Firm launch contracts with solid pricing, improving gross margin, and lower cash burn would also support the thesis. A constructive March 3 earnings update could extend momentum if guidance tops expectations.

Global Market Insights

RKLB Stock Today, January 07: Record High Fuels Neutron Risk Debate

ByDanny Kontos January 8, 2026January 8, 2026

Rocket Lab stock sprinted to a fresh peak near US$79.83 on January 7 as space names rallied. Shares of RKLB now sit at rich levels, with price to sales near 79 and price to book near 35. Profit remains negative at US$-0.38 EPS. The path forward leans on Neutron’s first flight, targeted for mid 2026. Any Neutron rocket delay, or SpaceX pricing pressure, could hit margins and sentiment. For Canadian investors, the setup offers growth potential, but also USD exposure and high volatility to manage.